Cases & Deals

  • Home
  • Practices
  • Alizé Pharma 3 raises €67 million in financing round

Share

Alizé Pharma 3 raises €67 million in financing round

July 2019

Client(s) Alizé Pharma 3 SAS

Jones Day represented Alizé Pharma 3 SAS, a French company engaged in the research and development of new therapeutic strategies for the treatment of rare endocrine and metabolic diseases, in connection with its €67 million (US$75 million) round of financing led by LSP, and included a syndicate of international investors.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.